Enhancement of the solubility of human tissue inhibitor of matrix metallocroteinase-2 (TIMP-2) in E. coli using a modified in vitro mutagenesis |
Kim, Jong-Uk
(Department of Molecular Sciences and Technology, Ajou University)
Choi, Dong-Soon (Department of Obstetrics and Gynecology, School of Medicine, Ajou University) Joo, Hyun (Mitochondrial Signaling Laboratory, Department of Molecular Physiology & Biophysics, College of Medicine, Inje University) Min, Churl-K. (Department of Molecular Sciences and Technology, Ajou University) |
1 | Kamiya, H., M. Ito, and H. Harashirna (2007), Induction of various mutations during PCRs with manganese and 8-hydroxy-dGTP. BioI. Pharm. Bull. 4, 842-844 |
2 | Cadwell, R. C., and G. F. Joyce (1992), Randomization of genes by PCR mutagenesis. PCR Methods Appl. 2, 28-33 DOI ScienceOn |
3 | Miyazaki, K. (2002), Random DNA fragmentation with endonuclease V application to DNA shuffling. Nucleic Acids Res. 30, e139 DOI ScienceOn |
4 | Zhao, H. and F. Arnold (1999), Directed evolution converts subtilisin E into a functional equivalent of thermitase. Protein Engineering 12, 47-53 DOI |
5 | Jermutus, L., A. Honegger, F. Schwesinger, J. Hanes, and A. Pluckthun (2001), Tailoring in vitro evolution for protein affmily or stability. Proc. Natl. Acad. Sci. USA 94, 4504-4509 |
6 | Stemmer, W. P. C. (1994), Rapid evolution of a protein in vitro by DNA shuffling. Nature 370, 389-391 DOI ScienceOn |
7 | Butler, G. S., M. Hutton, B. A Wattam, F. Willenbrock, and G. Murphy (1999), The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations. J. BioI. Chem. 274, 20391-20396 DOI |
8 | Stetler-Stevenson, W. G., S. Aznavoorian, and L. A Liotta (1993), Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell BioI. 9, 541-573 DOI ScienceOn |
9 | Hernandez-Barrantes, S., M. Toth, M. M. Bernardo, M. Yurkova, D. C. Gervasi, Y. Raz, Q. A. Sang, R. Fridman (2000), Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TlMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. BioI. Chem. 275, 12080-12089 DOI ScienceOn |
10 | Frederick, W. M., A. F. Tom, F. James, B. F. Robert, D. C. Mark, and A. W. Richard (1998), High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinases-3. J. BioI. Chem. 273, 21736-21743 DOI ScienceOn |
11 | Boyd, R. S., and F. R. Balkwill (1999), MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br. J. Cancer 80, 315-321 DOI ScienceOn |
12 | Westerlund, A., P. U. Hujanen, and T. Turpeenniemi-Hujanen (1997), Fibroblasts srimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2). Gynecol. Oncol. 67, 76-82 DOI ScienceOn |
13 | Negro, A., M. Onisto, L. Masiero, and S. Garbisa (1995), Synthesis and refolding of human TIMP-2 from E coli, with specific activity for MMP-2. FEBS Lett. 360, 52-56 DOI ScienceOn |
14 | Baker, A. H., D. R. Edwaro;, and G. Murphy (2002), Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727 DOI |
15 | Joo, H., Z. Lin, and F. Arnold (1999), Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature 399, 670-672 DOI ScienceOn |
16 | Altamirao, M. M., J. M. Blackburn, C. Aguayo, and A. R. Fersht (2000), Directed evolution of new catalytic activity using the alphafbeta-barrel scaffold. Nature 403, 617-622 DOI ScienceOn |
17 | Zhao, H. and F. Arnold (1997), Optimization of DNA shuffling for high fidelity recombination. Nucleic Acids Res. 25, 1307-1308 DOI ScienceOn |
18 | Mannello, F., G. Gazzanelli (2001), Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6, 479-482 DOI ScienceOn |
19 | Williamson, R. A. (2001), Refolding of TIMP-2 from Escherichia coli inclusion bodies. Methods Mol. BioI. 151, 257-265 |
20 | Maquoi, E., F. Frankenne, E. Baramova, C. Munaut, N. E. Sounni, A. Remacle, A. Noel, G. Murphy, and J.-M. Foidart (2000), Membrane type-1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell line. J. Biol. Chem. 276, 11368-11378 |
21 | Crameri, A., S. Raillard, E. Bermudez, W. P. Stemmer (1998), DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 391, 288-291 DOI ScienceOn |
22 | McDonnell, S., V. Chaudhry, J. Mansilla-Soto, Z. S. Zeng, W. Shu, and J. G. Guillem (1999), Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo. Clin. Exp. Metastasis 17, 341-349 |
23 | Miyazaki, K., P. L. Wintrode, R. A. Grayling, D. N. Rubingh, and F. Arnold (2000), Directed evolution study of temperature adaptation in a psychrophilic enzyme. J. Mol. Biol. 297, 1015-1026 DOI ScienceOn |
24 | Fassina, G., N. Ferrari, C. Brigati, R. Benelli, L. Santi, D. M. Noonan, and A. Albini (2000), Tissue inhibitors of metalloproteinases: regulation and biological activities. Clin. Exp. Metastasis 18, 111-120 DOI |
25 | Maxwell, K. L., A. K. Mittermaier, J. D. Forman-Kay, and A. R. Davidson (1999), A simple in vivo assay for increased protein solubility. Protein Sci. 8, 1908-1911 DOI ScienceOn |
26 | Itoh, T., M. Tanioka, H. Matsuda, H. Nishimoto, T. Yoshioka, R. Suzuki, and M. Uehira (1999), Experimental metastasis is suppressed in MMP-9-deficient mice. Clin. Exp. Metastasis 17, 177-181 DOI ScienceOn |
27 | Zhang, J. H., G. Dawes, and W. P. Stemmer (1997), Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening. Proc. Natl. Acad. Sci. USA 94, 4504-4509 |
28 | Shao, Z., H. Zhao, L. Giver, and F. H. Arnold (1997), Randompriming in vitro recombination: an effective tool for directed evolution. Nucleic Acids. Res. 26, 681-683 DOI |
29 | Cochran, J. R., C. Y. Kim, S. M. Lippow, B. Rao, and K. D. Wittrup (2006), Improved mutants from directed evolution are biased to orthologous substitutions. Protein Eng. Des. Sel. 19, 245-253 DOI ScienceOn |
30 | Aguinaldo, A. M., and F. Arnold (2003), Staggered extension process (StEP) in vitro recombination. Methods Mol. Biol. 192, 105-110 |
31 | Waldo, G. S. (2003), Genetic screens and directed evolution for protein solubility. Curr. Opi. Chem. BioI. 7, 33-38 DOI ScienceOn |
32 | Kawate, H., D. M. Landis, and L. Loeb (2002), Distribution of mutations in human thymidylate syntltase yielding resistance to 5-fluorodeoxyuridine. J. BioI. Chem. 277, 36304-36311 DOI ScienceOn |
33 | Stemmer, W. P. (1994), DNA shuffling by random fragmentation and reassembly: In vitro recombirtation for molecular evolution. Proc. Natl. Acad. Sci. USA 91, 10747-10751 |
34 | Park, Y. H., H. S. Ryu, D. S. Choi, K. H. Chang, D. W. Park, and C. K. Min (2003), Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int. J. Gynecol. Cancer 13, 53-60 DOI ScienceOn |
35 | Zhao, H., L. Giver, Z. Shao, J. A. Affholter, and F. H. Arnold (1998), Molecular evolution by staggered extension process (StEP) in vitro recombination. Nat. Biotech. 16, 258-261 DOI ScienceOn |
36 | Waldo, G. S., B. M. Standish, J. Berendzen, and T. C. Terwilliger (1999), Rapid protein folding assay using green fluorescent protein. Nat. Biotech. 17, 691-695 DOI ScienceOn |
37 | Lesley, S. A., J. Graziano, C. Y. Cho, M. W. Knuth, H. E. Klock (2002), Gene expression response to misfolded protein as a screen for soluble recombinant protein. Protein engineering 15, 153-160 DOI |